Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

169
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
169

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Understanding dietary beliefs, behaviors, and barriers in inflammatory bowel disease: A scoping review.

Clinical nutrition ESPEN·2025
Same author

Upadacitinib in the treatment of difficult-to-treat psoriatic arthritis.

Journal of the European Academy of Dermatology and Venereology : JEADV·2024
Same author

Merkel-cell carcinoma: ESMO-EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-up.

ESMO open·2024
Same author

Clinical determinants of clinical response to Sonidegib in advanced basal cell carcinoma: a monocenter experience.

European review for medical and pharmacological sciences·2024
Same author

Effects of pioglitazone on the differentiation and inflammation in vitiligo keratinocytes.

Journal of the European Academy of Dermatology and Venereology : JEADV·2024
Same author

The concept of bank tissue applied to post bariatric abdominoplasty: The use of autologous dermal mesh for abdominal diastasis repair.

Journal of plastic, reconstructive & aesthetic surgery : JPRAS·2022

相关实验视频

Updated: Jul 4, 2025

Combination of High Ligation and Intraoperative Embolization using Polidocanol for Treatment of Varicoceles
02:58

Combination of High Ligation and Intraoperative Embolization using Polidocanol for Treatment of Varicoceles

Published on: December 22, 2023

395

混合合作综合体降低VAS得分和增强性功能在女性的状状硬化.

M Tedesco1, L Alei, A Bonadies

  • 1Department of Plastic and Regenerative Surgery, San Gallicano Dermatological Institute IRCCS, Rome, Italy. marinella.tedesco@ifo.it.

European review for medical and pharmacological sciences
|February 2, 2024
PubMed
概括

氨酸混合合作复合物 (HCC) 注射有效地治疗绝经期妇女的阴道样硬化症 (VLS). 治疗显著改善了干燥和性功能,没有报告的副作用.

更多相关视频

Optimizing the Modified No-Scalpel Vasectomy Technique
04:47

Optimizing the Modified No-Scalpel Vasectomy Technique

Published on: October 18, 2024

334
Laparoscopic Oocyte Retrieval and Cryopreservation during Vaginoplasty for Treatment of Mayer-Rokitansky-Kuster-Hauser Syndrome
11:53

Laparoscopic Oocyte Retrieval and Cryopreservation during Vaginoplasty for Treatment of Mayer-Rokitansky-Kuster-Hauser Syndrome

Published on: May 10, 2022

3.6K

相关实验视频

Last Updated: Jul 4, 2025

Combination of High Ligation and Intraoperative Embolization using Polidocanol for Treatment of Varicoceles
02:58

Combination of High Ligation and Intraoperative Embolization using Polidocanol for Treatment of Varicoceles

Published on: December 22, 2023

395
Optimizing the Modified No-Scalpel Vasectomy Technique
04:47

Optimizing the Modified No-Scalpel Vasectomy Technique

Published on: October 18, 2024

334
Laparoscopic Oocyte Retrieval and Cryopreservation during Vaginoplasty for Treatment of Mayer-Rokitansky-Kuster-Hauser Syndrome
11:53

Laparoscopic Oocyte Retrieval and Cryopreservation during Vaginoplasty for Treatment of Mayer-Rokitansky-Kuster-Hauser Syndrome

Published on: May 10, 2022

3.6K

科学领域:

  • 皮肤病学 皮肤病学
  • 妇科 妇科医生 妇科
  • 妇女健康 妇女健康

背景情况:

  • Vulvar lichen sclerosus (VLS) 是一种慢性炎症性皮肤疾病,在更年期妇女中引起显著的不适和性功能障碍.
  • 常见的症状包括,灼热,刺痛和疼痛,影响生活质量.

研究的目的:

  • 研究氨酸混合合作综合体 (HCC) 治疗更年期妇女VLS的疗效.
  • 评估HCC对VLS症状和性功能的影响.

主要方法:

  • 一项前性单中心研究,涉及30名患有VLS的更年期妇女.
  • 患者接受了两个HCC注射 (32 mg/ml) 间隔一个月.
  • 经过验证的问卷 (VAS,FSFI) 在基线和随访时评估了疼痛,,干燥和性功能.

主要成果:

  • 在HCC治疗后没有报告任何不良副作用.
  • 观察到干燥的统计显著减少 (p=0.038) 和改善性功能,特别是滑 (p=0.001) 和高潮 (p=0.001).
  • 观察到疼痛和的强度下降的趋势.

结论:

  • 氨酸混合合作复合物 (HCC) 在更年期妇女治疗VLS方面显示出有前途的疗效.
  • HCC为改善VLS相关症状和性功能提供了安全有效的治疗选择.